全程化管理临床路径在非晚期结肠癌患者中的应用

发布时间：2018-11-13 19:13

【摘要】：目的以全程化管理理念,探索非晚期结肠癌的临床路径,以促进结肠癌的规范化诊疗。方法以结肠癌治疗指南为基础,将符合入径管理的非晚期结肠癌从诊断到治疗全过程纳入路径管理,设计结肠癌诊疗全程化临床路径,预期目标完成路径率(完成路径者/入路径者)≥70%,非预见内的变异率(非预见内的变异/入路径者)10%。结果共收治96例新诊的非晚期结肠癌患者,完成路径率93.8%(90/96),变异率6.3%(6/96)。诊断与分期阶段、根治性手术阶段平均花费时间分别为(16.7±16.9)d和(18.8±10.1)d。辅助化疗阶段平均住院时间为(1.04±0.9)d。手术住院的平均费用为(40 166.6±11 450.5)元,药品比例11%。辅助化疗的平均费用为(84 541.4±46 117.8)元。结论全程化管理非晚期结肠癌的临床路径获得较高的路径完成率,较低的变异率,较低的平均化疗住院时间,较低的药品比例,提示该路径管理方法切实可行,值得推广。
[Abstract]:Objective to explore the clinical pathway of non-advanced colon cancer in order to promote the standardized diagnosis and treatment of colon cancer. Methods based on the treatment guidelines of colon cancer, the whole process of diagnosis and treatment of non-advanced colon cancer was included in the path management, and the whole clinical path of diagnosis and treatment of colon cancer was designed. The expected goal completion path rate (completion path / entry path player) is 鈮，

本文编号：2330173